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ABSTRACT The nematode Caenorhabditis el-
egans is an excellent model organism for studies
of glycan dynamics, a goal that requires tools
for imaging glycans in vivo. Here we applied the
bioorthogonal chemical reporter technique for
the molecular imaging of mucin-type O-glycans
in live C. elegans. We treated worms with azido-
sugar variants of N-acetylglucosamine (GlcNAc),
N-acetylgalactosamine (GalNAc), and
N-acetylmannosamine (ManNAc), resulting in
the metabolic labeling of their cell-surface gly-
cans with azides. Subsequently, the worms were
reacted via copper-free click reaction with
ﬂuorophore-conjugated diﬂuorinated cyclo-
octyne (DIFO) reagents. We identiﬁed prominent
localization of mucins in the pharynx of all four
larval stages, in the adult hermaphrodite phar-
ynx, vulva and anus, and in the tail of the adult
male. Using a multicolor, time-resolved imaging
strategy, we found that the distribution and dy-
namics of the glycans varied anatomically and
with respect to developmental stage.
C
aenorhabditis elegans glycans are
attractive targets for molecular imag-
ing. As a well-established model or-
ganism, C. elegans offers a system in which
to probe the dynamics of glycans in devel-
opment, disease, and normal physiological
processes.Further,glycanshavebeendocu-
mented as key players in C. elegans biol-
ogy. For example, vulval morphogenesis
andearlyembryocytokinesisrequirethegly-
cosaminoglycan chondroitin sulfate (1, 2).
Each stage of C. elegans development is as-
sociated with speciﬁc N-glycan structures,
and anatomical features such as the cuticle,
vulva, and male tail possess a repertoire of
mucin-type O-glycans (3–5). Nevertheless,
the dynamics of C. elegans glycans have re-
mained obscure because they have been in-
accessibletoanalysisbymolecularimaging.
Here we applied the bioorthogonal
chemical reporter strategy (6), which we re-
cently described for imaging glycans in de-
veloping zebraﬁsh (7), to the molecular im-
agingofglycansinliveC.elegans.Intheﬁrst
step, we metabolically incorporate an azido-
sugar into the worm’s glycans by using
their own biosynthetic machinery (Figure 1,
panel a). Per-O-acetylated azidosugars pas-
sively diffuse into the cells where their hy-
droxyl groups are deacetylated by promiscu-
ous intracellular esterases (8). The free
sugar is processed and integrated into
newly synthesized glycans, some of which
are displayed on cell-surface glycoconju-
gates. The azidosugars are then imaged in
a second step with diﬂuorinated cyclo-
octyne (DIFO)-based probes (Figure 1,
panel b) via copper-free click chemistry (9).
Additionally, azide-labeled glycoconjugates
can be analyzed ex vivo by reaction of tissue
lysates with alkyne- or triarylphosphine-
based probes (e.g., via the Staudinger liga-
tion (10)) followed by Western blot.
Because the metabolism of azidosugars
in nonvertebrate animals has not been
tested, we ﬁrst assayed the ability of
C. elegans to incorporate azido analogues
of ManNAc, GalNAc, and GlcNAc into glyco-
proteins. We seeded nematode growth me-
dium (NGM)-agar plates containing 1 mM
per-O-acetylated N-azidoacetylmanno-
samine (Ac4ManNAz), -galactosamine
(Ac4GalNAz), or -glucosamine (Ac4GlcNAz)
with 10 larval (L1) wild-type C. elegans
(strain N2). We allowed the population of
worms to expand until the bacterial food
source was consumed. Then, we made ly-
sates from the mixed-stage population of
worms, reacted them with phosphine-Flag,
and analyzed the resident glycoproteins for
the presence of azides using standard West-
ern blot techniques (Figure 1, panel c). We
observed robust incorporation of GalNAz
into glycoproteins, indicating that C. ele-
gans’ metabolic enzymes are tolerant of this
azidosugar. Samples from Ac4GlcNAz- and
Ac4ManNAz-treated worms produced no ob-
servable signal in the Western blot, indicat-
ing that these azidosugars are not incorpo-
rated into C. elegans glycans at signiﬁcant
levels. This was not unexpected because, in
mammalian cells, GlcNAz is incorporated
into cytosolic O-GlcNAcylated proteins at
low levels with no signiﬁcant cell-surface
glycoprotein labeling (11). ManNAz is con-
verted by mammalian cells to the corre-
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that is absent in C. elegans (12).
We sought to determine the types of gly-
coproteins being labeled by Ac4GalNAz.
The naturally occurring counterpart of Gal-
NAz, GalNAc, is found in mucin-type
O-glycans (13), chondroitin sulfate (14),
and rarely, N-glycans (15). In order to
probe for GalNAz residues within chon-
droitin sulfate and N-glycans, we reacted
lysates from Ac4GalNAz-treated C. elegans
with chondroitinase ABC or peptide
N-glycosidase F (PNGase F), enzymes that
digest the respective glycans. Then, we re-
acted the enzyme-treated lysates with
phosphine-Flag and probed the glyco-
proteins by Western blotting with an -Flag
antibody. Neither enzyme-treated sample
showed a signiﬁcant decrease in chemilu-
minescence signal compared to undi-
gested lysate (Supplementary Figure 1a,b),
indicating that a majority of GalNAz resi-
dues are situated in other types of
glycans.
We recently found that mammalian cells
epimerize the nucleotide sugar derived from
GalNAz, uridine diphosphatidyl (UDP)-
GalNAz, to UDP-GlcNAz and that the en-
zyme O-GlcNAc transferase (OGT) further in-
stalls the azidosugar on nuclear and cyto-
plasmic proteins that would normally be
O-GlcNAcylated (16). In order to determine
if this phenomenon occurs in worms, we
treated an OGT-deﬁcient C. elegans strain,
RB653 (17), with Ac4GalNAz. Western blots
of phosphine-Flag-labeled lysates from
Ac4GalNAz-treatedRB653wormswereindis-
tinguishable from similarly treated wild-
type samples (Supplementary Figure 1c).
This observation suggests that GalNAz does
not metabolically label O-GlcNAcylated
proteins appreciably in this organism.
Finally, we probed the binding of the
azide-labeled glycoproteins to lectins spe-
ciﬁc for N- or O-glycans. We observed no de-
tectable binding of azide-labeled glyco-
proteins to the N-glycan speciﬁc lectin
concanavalin A (ConA), consistent with
the hypothesis that a majority of labeled
glycans are O-linked. Moreover, a small frac-
tion of GalNAz-labeled species were re-
tained on peanut agglutinin (PNA)-
conjugated agarose beads, and judging by
the faint chemiluminescence signal of the
relevant phosphine-Flag-modiﬁed sample,
some of them were selectively eluted with
galactose (Supplementary Figure 2). These
results indicate that only a subset of
GalNAz-labeled glycoproteins possess the
unmodiﬁed form of the core 1 O-glycan,
galactose1–3GalNAc, which is recognized
by PNA (18). That only a fraction of GalNAz-
labeled glycoproteins bound to PNA-
agarose was not unexpected because
C. elegans O-glycans possess extended pe-
ripheral structures that would mask the PNA
epitope (19).
Collectively, our in vitro characterization
experiments suggest that GalNAz is incorpo-
rated into mucin-type O-glycans in C. ele-
gans. We should note, however, that West-
ern blot analysis of lysates does not probe
glycolipids, which may possess GalNAc resi-
dues (20), nor does the technique analyze
those species that are not soluble in the de-
tergent lysis buffer. Thus, we cannot rule
out the possibility that other glycans, such
as insoluble cuticle-associated chondroitin
sulfateproteoglycans(21),aremetabolically
labeled with GalNAz.
We next sought to image the azide-
labeled glycans in live C. elegans in order
to reveal their anatomical distribution at dif-
ferent stages of development. To accom-
plish this, we employed copper-free click
chemistry using an Alexa Fluor 488-
conjugated DIFO reagent termed DIFO-488
(9). Strains N2 or CA151 were grown with or
without 5 mM Ac4GalNAz as described
above. The CA151 strain contains a him-8
(high incidence of males) mutation that im-
pairs X chromosome segregation, resulting
Figure 1. A bioorthogonal chemical reporter strategy for in vivo imaging of glycans in C. elegans.
a) C. elegans embryos metabolize azidosugars and incorporate them into newly synthesized
cell-surface glycans (blue). Copper-free click chemistry with ﬂuorophore-conjugated diﬂuori-
nated cyclooctyne (DIFO) reagents (green) enables imaging of glycans by ﬂuorescence micros-
copy. b) The DIFO-488 and -568 probes used in this study. c) Lysates from mixed-stage C. ele-
gans that had been incubated with Ac4GlcNAz, Ac4GalNAz, or Ac4ManNAz were reacted with
phosphine-Flag and subsequently analyzed by Western blot, probing with HRP-conjugated
-Flag clone M2 (top panel) or mouse -actin (bottom panel).
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pared to the wild-type occurrence of 0.1%)
and thus allows the visualization of male-
speciﬁc structures (22).
Mixed-stage populations of Ac4GalNAz-
treated or untreated (“no sugar”) C. elegans
were reacted with DIFO-488 for 1 h, washed
brieﬂy, and then anesthetized prior to imag-
ing (Figure 2). In the adult hermaphrodite,
we observed GalNAz-speciﬁc labeling in
the pharynx, vulva, and anus (Figure 2, pan-
els a–d). The labeled glycans were concen-
trated in the pharynx of all larval and adult
worms (Figure 2, panels a, b, e), though
higher exposure times did reveal some
staining of the worms’ outer coat, the cu-
ticle (Figure 2, panel d). Like the adult her-
maphrodites, the adult males stained in-
tensely in the pharynx region and minimally
in the anus and cuticle. However, the male
tail also showed striking labeling of the fan,
spicule, and rays (Figure 2, panel f). Since
the C. elegans cuticle is notoriously impen-
etrable by small molecules (23), we suspect
that Ac4GalNAz enters the worm by inges-
tion. The intense ﬂuorescence observed in
the pharynx is consistent with this presump-
tion. Control worms that were not incu-
bated with azidosugar showed minimal
background ﬂuorescence, and neither
azidosugar metabolism nor DIFO-488 label-
ing produced observable toxicity. Impor-
tantly, the observed ﬂuorescence is not due
to Escherichia coli reacting with DIFO-
conjugates and adhering to the worms.
E. coli were visible in high magniﬁcation im-
ages next to worms and were not labeled
with DIFO-ﬂuorophore conjugates (Supple-
mentary Figure 3).
The one-color labeling protocol enabled
the visualization of the GalNAz-containing
glycans that were produced throughout
C. elegans larval development and into
adulthood; however, this strategy does not
highlight nascent glycans, as would be nec-
essary to study their dynamics. To identify
“hot spots” of O-glycan biosynthesis, we
employed a two-color labeling strategy
(Figure 3, panel a). We metabolically la-
beled mixed-stage strains N2 and CA151
with Ac4GalNAz and then reacted the worms
with DIFO-488 as described above. We
then transferred the specimens back to
plates containing Ac4GalNAz (or to control
plates) for an additional 12 h. During this
second incubation, only the newly synthe-
sized glycans were metabolically labeled
with GalNAz. We reacted these worms with
Alexa Fluor 568-conjugated DIFO (DIFO-568,
Figure 1, panel b). Thus, at the end of the
two labeling steps, the older population of
glycans should be labeled with DIFO-488
(false-colored green) and the newer glycans
with DIFO-568 (false-colored red). The ana-
tomical distributions of the two dyes at vari-
ous developmental stages were then ana-
lyzed by ﬂuorescence imaging of live
anesthetized worms.
Figure 3, panel b shows two-color ﬂuores-
cenceimagesofwormsatthreedifferentde-
velopmental stages: L1, L2, and adult.
Worms in the ﬁrst larval stage (L1) when
the image was acquired would have been
eggs at the time of the initial labeling reac-
tion. Accordingly, these worms show no la-
beling with DIFO-488 (green) but intense la-
beling with DIFO-568 (red), which was
administered 12 h later (Figure 3, panel b,
top row). By contrast, worms in the second
larval stage (L2) when the image was ac-
quired were in stage L1 during the DIFO-488
labeling reaction. These worms display
roughly equal and overlapping green and
red ﬂuorescence, indicating that O-glycans
were produced in the same anatomical re-
gions during the ﬁrst two larval stages. One
region of the L2 larvae labeled more in-
tensely with DIFO-568 (red) than with DIFO-
488: the posterior pharynx (also called the
“grinder,” marked in Figure 3, panel b by ar-
rowheads). This local increase in the pro-
duction of O-glycans was even more pro-
Figure 2. In vivo imaging of glycan distribution in larval and adult C. elegans.a )C. elegans adult
hermaphrodites that had been incubated with Ac4GalNAz () or no sugar (–) were reacted with
DIFO-488 and imaged alive. Fluorescence was observed in the pharynx (b), vulva (c), and anus
(d) of Ac4GalNAz-treated () but not in the no sugar control () worms. b–d) Higher magniﬁca-
tion images of the pharynx (b), vulva (c), and anus (d) regions. e) C. elegans hermaphrodites at
larval stage L1L4 that had been incubated with Ac4GalNAz () or no sugar () were reacted
with DIFO-488. Fluorescence was observed in the pharynx region of Ac4GalNAz-treated worms.
f) C. elegans strain CA151 adult males metabolically labeled with Ac4GalNAz () or no sugar ()
were reacted with DIFO-488. Fluorescence was observed in the tail region of Ac4GalNAz-treated
worms. DIC denotes differential interference contrast. 488 denotes DIFO-488 ﬂuorescence. Scale
bars: (a) 100 m; (b–f) 25 m.
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marked by arrowheads).
In the adult vulva, the products from
both labeling reactions were apparent,
though the DIFO-568 ﬂuorescence signal
was less intense. The limited ﬂuorescence
associated with new glycans indicates that
O-glycan biosynthesis occurred at relatively
low levels in the vulva of adult hermaphro-
dites (Figure 3, panel c). In the male sex
organs, we observed intense DIFO-488
labeling of the fan but minimal DIFO-568
labeling. Rather, the DIFO-568 highlighted
the spicule and cloaca, indicating that new
glycans are continually produced in these
areas in the adult worm (Figure 3, panel d).
These components of the male sex organs
are known to have motive capabilities (24),
a property shared with the pharynx (25). It is
possible that mucin-type O-glycan produc-
tion is required to supply lubricating mucin
glycoproteins for these processes (26). Also,
the organs most readily labeled with DIFO
probes are those that are accessible to solu-
tion (i.e., pharynx, vulva, and male tail).
This observation most likely reﬂects the
Alexa Fluor probes’ limited penetrance into
the organism. Thus, an important area of fu-
ture optimization involves the development
of ﬂuorescent dyes capable of greater dis-
semination among the tissues of live
worms.
In conclusion, we demonstrated that
O-glycans can be imaged in live C. elegans,
enablingstudiesoftheirdistributionanddy-
namicsfromlarvaetoadulthoodinbothher-
maphrodites and males. The technique
may also have utility in other studies of
C. elegans glycobiology that would beneﬁt
from spatial and temporal resolution, such
as pathogenesis or aging.
METHODS
Materials and General Methods. All chemicals
were of analytical grade, obtained from commer-
cial suppliers, and used without further puriﬁca-
tion. Phosphine-Flag, DIFO-488, DIFO-568,
Ac4GalNAz, Ac4ManNAz, and Ac4GlcNAz were syn-
thesized as previously described (9, 16, 27).
C. elegans strains N2, CA151, and RB653 were ob-
tained from the C. elegans Genetics Center. -Actin
clone C4 was obtained from AbCAM. Phosphate-
buffered saline solution without calcium and mag-
nesium (PBS) and SeeBlue Plus2 prestained pro-
tein molecular weight markers were obtained from
Invitrogen Life Technologies, Inc. Nematode
growth media (NGM) was obtained from United
States Biological. Complete mini protease inhibi-
tor tablets with ethylene diamine tetraacetic acid
(EDTA) were obtained from Roche Applied Bio-
sciences. Bis-Tris polyacrylamide gels and the
detergent-compatible (DC) protein assay kit were
obtained from Bio-Rad. HRP-conjugated -mouse
IgG was obtained from Jackson ImmunoResearch
Laboratories. Peptide N-glycosidase F (PNGase F)
was obtained from New England Biolabs. Restore
Western blot stripping buffer and SuperSignal
West Pico chemiluminescent substrate were ob-
tained from Pierce Biotechnology. -Chondroitin
sulfate Di-Os was obtained from Seikagaku Cor-
poration. Chondroitinase ABC from Proteus vul-
garis, HRP-conjugated -Flag clone M2, Nonidet P
40 Substitute, Ponceau S, and RNase B were ob-
tained from Sigma-Aldrich.
Figure 3. Two-color imaging of nascent glycans in live C. elegans.a )C. elegans embryos that
were previously labeled with Ac4GalNAz and reacted with DIFO-488 (green) were incubated again
with Ac4GalNAz to metabolically label a second, newer population of glycans with azides (blue).
These newly labeled glycans were then reacted with DIFO-568 (red) to distinguish the old from
the new populations. b) L1 (top panels), L2 (middle panels), or adult (bottom panels) C. elegans
metabolically labeled with Ac4GalNAz were reacted with DIFO-488 and DIFO-568 as described in
panel a. Arrowheads denote the “grinder” in the anterior pharynx region. c, d) Strain N2 adult
hermaphrodite (c) or strain CA151 adult male (d) C. elegans that were metabolically labeled with
Ac4GalNAz were reacted with DIFO-488 and DIFO-568 as described in panel a. DIC denotes dif-
ferential interference contrast, 488 denotes DIFO-488 ﬂuorescence, and 568 denotes DIFO-568
ﬂuorescence. Scale bars: (b, d) 25 m; (c) 10 m.
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Misonix Sonicator 3000 equipped with a micro-
probe. Images were acquired with a Zeiss Axio-
vert 200 M deconvolution microscope, decon-
volved using the nearest neighbor deconvolution
algorithm of Slidebook (Intelligent Imaging Innova-
tions), and displayed as a maximum intensity pro-
jection of the Z-axis.
Labeling C. elegans Glycans with Azidosugars.
Wild-type (strain N2), him-8(me4) mutants (strain
CA151), and ogt mutants (strain RB653) were
maintained on NGM agar plates with E. coli (strain
OP50) at 21 °C. For metabolic labeling experi-
ments, a 10-cm Petri dish containing NGM plus
1 mM (Western blot experiments) or 5 mM (imag-
ing experiments) of Ac4GlcNAz, Ac4GalNAz,
Ac4ManNAz, or negative control was inoculated
with 100 L of an OP50 culture that had an opti-
cal density at 600 nm (OD600) of 50, and these
plates were grown for 24 h at 37 °C. To each plate
were added 10 L1 C. elegans of the appropriate
strain and the population was grown at 21 °C for
8 d, or until the bacterial lawn was consumed.
Phosphine-FlagReactionwithC.elegansLysates.
Ac4GlcNAz-, Ac4GalNAz-, Ac4ManNAz-, or negative
control-treated mixed-staged C. elegans were
washed from the NGM agar plate with 4  2.5 mL
PBS into a 15-mL centrifuge tube. The worms were
concentrated by centrifugation (100  g, 3 min,
4 °C), the supernatant was removed, and 10 mL of
PBS was added. This wash process was repeated
twice more for a total of three washes. The washed
worms were then transferred to a 1.5-mL eppen-
dorf tube and concentrated by centrifugation
(100  g, 3 min, 4 °C), the supernatant was re-
moved, and 200 L of ice cold lysis buffer was
added (150 mM NaCl, 20 mM Tris pH 7.4, 1% Non-
idet P 40 Substitute, and one Roche complete
mini protease inhibitor tablet with EDTA for every
10 mL of lysis buffer). The worms were disrupted
by sonication on ice with 30-s, 9-W pulses three
times, and then insoluble debris was removed by
centrifugation (16,000  g, 10 min, 4 °C). The pro-
tein concentration was determined using the Bio-
RAD DC protein assay. Ten micrograms of total pro-
tein from these lysates were reacted for 12 h at
21 °C with 250 M Phosphine-Flag and subse-
quently assayed using standard Western blot pro-
cedures, probing with a 1:5000 dilution of HRP-
conjugated -Flag clone M2.
Live Imaging of GalNAz-Labeled C. elegans.
Mixed-stage strain N2 or CA151 C. elegans that
had been metabolically labeled with 5 mM
Ac4GalNAz were reacted with 100 Lo f1 0 0M
DIFO-488 in PBS for1ha t2 1° C .After 1 h, the re-
action was quenched by dilution to 10 mL with
PBS. The worms were washed by centrifugation
six times in 10 mL PBS (100  g, 3 min, 4 °C). For
the one-color imaging experiments, the worms
were anesthetized with 10 mM NaN3 and imaged
with a Zeiss Axiovert 200 M deconvolution micro-
scope. For the two-color imaging experiments, the
worms were transferred from the ﬁnal PBS wash to
10-cm NGM plates containing 5 mM Ac4GalNAz or
no sugar as a negative control. After 12 h, the
worms were reacted with 100 Lo f1 0 0M DIFO-
5 6 8i nP B Sf o r1ha t2 1° C ,washed, and imaged
as described above for the one-color experiment.
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